The Acne Spot Treatment (87415-100-04)

Manufacturer
Spotless, Inc.
Effective date
2026-08-30
Label type
HUMAN OTC DRUG LABEL
Version
2
Source
daily-update
Hydrated at
2026-09-02 00:03:28

Label at a glance#

ProductThe Acne Spot Treatment
Active ingredientSALICYLIC ACID
Label structure8 sections

Indications and uses

• for treatment of acne

Dosage and administration

• Clean the skin thoroughly before applying this product. • Cover the entire affected area with a thin layer one to three times daily • Because excessive drying of the skin may occur, start with one application daily, then gradually increase to two times daily if needed or as directed by a doctor • If bothersome dryness or peeling occurs, reduce application to once a day or every other day • Always wear sunscreen ...

Label contents#

Full prescribing information#

Drug Facts

DOSAGE & ADMINISTRATION SECTION

Drug Facts

Active ingredients

OTC - ACTIVE INGREDIENT SECTION

Salicylic Acid 2%

Purpose

OTC - PURPOSE SECTION

Acne Medication

Uses

INDICATIONS & USAGE SECTION

• for treatment of acne

Warnings

WARNINGS SECTION

For external use only
Flammable, keep away from open fire or flame

OTC - WHEN USING SECTION

When using this product skin irritation and dryness is more likely to occur if you use another topical medication at the same time. If irritation occurs, only use one topical acne medication at a time.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children. If swallowed, get medical help or contact Poison Control Center right away. Avoid contact with eyes. If contact occurs, flush thoroughly with water.

Directions

INSTRUCTIONS FOR USE SECTION

• Clean the skin thoroughly before applying this product.
• Cover the entire affected area with a thin layer one to three times daily
• Because excessive drying of the skin may occur, start with one application daily, then gradually increase to two times daily if needed or as directed by a doctor
• If bothersome dryness or peeling occurs, reduce application to once a day or every other day
• Always wear sunscreen after daytime use

Inactive ingredients

INACTIVE INGREDIENT SECTION

Water, Niacinamide, Glycerin, Pentylene Glycol, Sodium Polyacrylate, Polyacrylate Crosspolymer-6, Epigallocatechin Gallatyl Glucoside, Epigallocatechin Gallate, Madecassoside, Zinc PCA, Sphingomonas Ferment Extract, Panthenol, Sodium Polyacryloyldimethyl Taurate, Caprylyl Glycol, Ethylhexylglycerin, Tocopherol

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Label

Spotless-12ml Tube w Ceramic Tip Folding Carton 23x23x113.5mm 7.2.26 Proof_Page_1Spotless-12ml Tube w Ceramic Tip Folding Carton 23x23x113.5mm 7.2.26 Proof_Page_1

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
dea2eded-d1e7-46bb-9a3d-f8dc20de6277Product name120190408

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 19 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
87415-10087415-100-04

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 17 matching rows.

Source Document#

Source XML

Older Hydrated Versions#

Version, Effective date, Source table
VersionEffective dateSourceHydrated
12026-02-05full-release2026-06-01 01:58:06

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
The Acne Spot TreatmentSALICYLIC ACID SPOTSpotless, Inc.4a1a3716-9eaf-6be4-e063-6294a90a31c32026-08-30WarningsExact identifier
ndc (package): 87415-100-04
ndc (product): 87415-100
ndc11 (package): 87415010004
spl id: 5a476d30-9bf2-1ca5-e063-6294a90a23e3
spl set id: 4a1a3716-9eaf-6be4-e063-6294a90a31c3

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.